161 related articles for article (PubMed ID: 37212949)
1. Factors affecting local control of bone metastases from radioresistant tumors treated with palliative external beam radiotherapy.
Makita K; Hamamoto Y; Kanzaki H; Nagasaki K; Takata N; Tsuruoka S; Uwatsu K; Kido T
Discov Oncol; 2023 May; 14(1):74. PubMed ID: 37212949
[TBL] [Abstract][Full Text] [Related]
2. Local control of bone metastases treated with external beam radiotherapy in recent years: a multicenter retrospective study.
Makita K; Hamamoto Y; Kanzaki H; Kataoka M; Yamamoto S; Nagasaki K; Ishikawa H; Takata N; Tsuruoka S; Uwatsu K; Kido T
Radiat Oncol; 2021 Nov; 16(1):225. PubMed ID: 34801042
[TBL] [Abstract][Full Text] [Related]
3. Local control after palliative external beam radiotherapy for bone metastases in patients with favorable prognosis.
Makita K; Hamamoto Y; Kanzaki H; Kataoka M; Yamamoto S; Nagasaki K; Ishikawa H; Takata N; Tsuruoka S; Uwatsu K; Kido T
Mol Clin Oncol; 2022 Nov; 17(5):152. PubMed ID: 36237604
[TBL] [Abstract][Full Text] [Related]
4. Factors Affecting Survival and Local Control in Patients with Bone Metastases Treated with Radiotherapy.
Makita K; Hamamoto Y; Kanzaki H; Nagasaki K; Takata N; Tsuruoka S; Uwatsu K; Kido T
Med Sci (Basel); 2023 Feb; 11(1):. PubMed ID: 36810484
[TBL] [Abstract][Full Text] [Related]
5. Local control of bone metastasis treated with palliative radiotherapy in patients with lung cancer: An observational retrospective cohort study.
Makita K; Hamamoto Y; Kanzaki H; Nagasaki K; Kozuki T
Oncol Lett; 2023 Jul; 26(1):303. PubMed ID: 37323814
[TBL] [Abstract][Full Text] [Related]
6. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.
Kupelian PA; Potters L; Khuntia D; Ciezki JP; Reddy CA; Reuther AM; Carlson TP; Klein EA
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):25-33. PubMed ID: 14697417
[TBL] [Abstract][Full Text] [Related]
7. Treatment intensity and control rates in combining external-beam radiotherapy and radioactive iodine therapy for metastatic or recurrent differentiated thyroid cancer.
Makita K; Hamamoto Y; Tsuruoka S; Takata N; Urashima Y; Miyagawa M; Mochizuki T
Int J Clin Oncol; 2020 Apr; 25(4):691-697. PubMed ID: 31897803
[TBL] [Abstract][Full Text] [Related]
8. External beam radiation therapy for advanced/unresectable malignant paraganglioma and pheochromocytoma.
Breen W; Bancos I; Young WF; Bible KC; Laack NN; Foote RL; Hallemeier CL
Adv Radiat Oncol; 2018; 3(1):25-29. PubMed ID: 29556576
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
10. Palliative external beam radiotherapy for the treatment of tumor bleeding in inoperable advanced gastric cancer.
Lee YH; Lee JW; Jang HS
BMC Cancer; 2017 Aug; 17(1):541. PubMed ID: 28800749
[TBL] [Abstract][Full Text] [Related]
11. Comparison of radiobiological parameters for
Gholami YH; Willowson KP; Forwood NJ; Harvie R; Hardcastle N; Bromley R; Ryu H; Yuen S; Howell VM; Kuncic Z; Bailey DL
EJNMMI Phys; 2018 Sep; 5(1):18. PubMed ID: 30175390
[TBL] [Abstract][Full Text] [Related]
12. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients.
Zeng ZC; Tang ZY; Fan J; Qin LX; Ye SL; Zhou J; Sun HC; Wang BL; Wang JH
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1067-76. PubMed ID: 15913915
[TBL] [Abstract][Full Text] [Related]
13. Pilot study of intraoperative high dose rate brachytherapy for head and neck cancer.
Nag S; Schuller D; Pak V; Young D; Grecula J; Bauer C; Samsami N
Radiother Oncol; 1996 Nov; 41(2):125-30. PubMed ID: 9004354
[TBL] [Abstract][Full Text] [Related]
14. Palliative radiation therapy for pulmonary metastases from hepatocellular carcinoma.
Jiang W; Zeng ZC; Zhang JY; Fan J; Zeng MS; Zhou J
Clin Exp Metastasis; 2012 Mar; 29(3):197-205. PubMed ID: 22173728
[TBL] [Abstract][Full Text] [Related]
15. Results of external-beam radiotherapy alone in invasive cancer of the uterine cervix: a retrospective analysis.
Saibishkumar EP; Patel FD; Sharma SC; Karunanidhi G; Sankar AS; Mallick I
Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):46-51. PubMed ID: 16477919
[TBL] [Abstract][Full Text] [Related]
16. Is it time to adopt external beam radiotherapy in the NCCN guidelines as a therapeutic strategy for intermediate/advanced hepatocellular carcinoma?
Jiang W; Zeng ZC
Oncology; 2013; 84 Suppl 1():69-74. PubMed ID: 23428862
[TBL] [Abstract][Full Text] [Related]
17. Soft tissue sarcomas treated with postoperative external beam radiotherapy with and without low-dose-rate brachytherapy.
Andrews SF; Anderson PR; Eisenberg BL; Hanlon AL; Pollack A
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):475-80. PubMed ID: 15145165
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy.
He J; Zeng ZC; Tang ZY; Fan J; Zhou J; Zeng MS; Wang JH; Sun J; Chen B; Yang P; Pan BS
Cancer; 2009 Jun; 115(12):2710-20. PubMed ID: 19382203
[TBL] [Abstract][Full Text] [Related]
19. Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiation Therapy.
Verma N; Laird JH; Moore NS; Hayman TJ; Housri N; Peters GW; Knowlton CA; Jairam V; Campbell AM; Park HS
Adv Radiat Oncol; 2024 Jun; 9(6):101500. PubMed ID: 38699671
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy for bone metastases of hepatocellular carcinoma: a hybrid systematic review with meta-analyses.
Rim CH; Park S; Yoon WS; Shin IS; Park HC
Int J Radiat Biol; 2023; 99(3):419-430. PubMed ID: 35758976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
